Skip to main content
Top
Published in: Annals of Surgical Oncology 1/2005

01-01-2005 | Editorial

Simplification of Breast Cancer Surgery

Author: Blake Cady, MD

Published in: Annals of Surgical Oncology | Issue 1/2005

Login to get access

Excerpt

The article by Mendez et al.1 in this issue of Annals of Surgical Oncology is a reminder that all of our current surgical beliefs and convictions constantly need reanalysis and revision (or substantiation, as the case may be). Surgical oncologists should constantly review their operations, pathophysiological understanding, and conclusions so that we can provide leadership to the general surgical community regarding the diagnosis and management of cancers. We must be aware of disease trends, new data that accumulate, and new interpretations of and possibilities for surgical care. Articles such as this remind us to be alert to new assumptions. Our clinical and scientific field should be moving toward more sophistication in the selectivity and segmentation of patients and the rationalization of diagnosis and treatment, balancing risk and benefit, financial costs and savings, morbidity versus improved health, and complexity in contrast to simplification. …
Literature
1.
go back to reference Mendez J, Fey J, Cody H, et al. Can sentinel lymph node biopsy be omitted in patients with favorable breast cancer histology? Ann Surg Oncol (in press) Mendez J, Fey J, Cody H, et al. Can sentinel lymph node biopsy be omitted in patients with favorable breast cancer histology? Ann Surg Oncol (in press)
2.
go back to reference Tabar, L, Smith, RA, Vitak, B, et al. 2003Mammographic screening: a key factor in the control of breast cancerCancer J 91527CrossRefPubMed Tabar, L, Smith, RA, Vitak, B,  et al. 2003Mammographic screening: a key factor in the control of breast cancerCancer J 91527CrossRefPubMed
3.
go back to reference Coburn, NG, Chung, MA, Fulton, J, et al. 2004Decreased breast cancer tumor size, stage, and mortality in Rhode Island: an example of a well-screened populationCancer Control1122230PubMed Coburn, NG, Chung, MA, Fulton, J,  et al. 2004Decreased breast cancer tumor size, stage, and mortality in Rhode Island: an example of a well-screened populationCancer Control1122230PubMed
4.
go back to reference Schwartz, GF, Guiliano, AE, Veronesi, U, et al. 2002Proceeding of the consensus conference of the role of sentinel lymph node biopsy in carcinoma or the breast April 19–22, 2001, Philadelphia, PA, USABreast J812638 Schwartz, GF, Guiliano, AE, Veronesi, U,  et al. 2002Proceeding of the consensus conference of the role of sentinel lymph node biopsy in carcinoma or the breast April 19–22, 2001, Philadelphia, PA, USABreast J812638
5.
go back to reference Fyles, AW, McCready, DR, Manchul, LA, et al. 2004Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancerN Engl J Med35196370PubMed Fyles, AW, McCready, DR, Manchul, LA,  et al. 2004Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancerN Engl J Med35196370PubMed
6.
go back to reference Hughes, KS, Schnaper, LA, Berry, D, et al. 2004Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancerN Engl J Med3519717PubMed Hughes, KS, Schnaper, LA, Berry, D,  et al. 2004Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancerN Engl J Med3519717PubMed
7.
go back to reference Smith, IE, Ross, GM 2004Breast radiotherapy after lumpectomy—no longer always necessaryN Engl J Med35110213PubMed Smith, IE, Ross, GM 2004Breast radiotherapy after lumpectomy—no longer always necessaryN Engl J Med35110213PubMed
8.
go back to reference Grogan, M, Tabar, L, Chua, B, et al. 2001Estimating the benefits of adjuvant systemic therapy for women with early breast cancerBr J Surg8815138PubMed Grogan, M, Tabar, L, Chua, B,  et al. 2001Estimating the benefits of adjuvant systemic therapy for women with early breast cancerBr J Surg8815138PubMed
9.
go back to reference Ravdin, PM, Siminoff, LA, Davis, GJ, et al. 2001Computer program to assist in making decisions about adjuvant therapy for women with early breast cancerJ Clin Oncol1998091PubMed Ravdin, PM, Siminoff, LA, Davis, GJ,  et al. 2001Computer program to assist in making decisions about adjuvant therapy for women with early breast cancerJ Clin Oncol1998091PubMed
10.
go back to reference Lee, SH, Chung, MA, Chelmow, D, et al. 2004Avoidance of adjuvant radiotherapy in selected patients with invasive breast cancerAnn Surg Oncol1131621PubMed Lee, SH, Chung, MA, Chelmow, D,  et al. 2004Avoidance of adjuvant radiotherapy in selected patients with invasive breast cancerAnn Surg Oncol1131621PubMed
11.
go back to reference Tabar, L, Tony Chen, HH, Amy Yen, MF, et al. 2004Mammographic tumor features can predict long-term outcomes reliably in women with 1–14-mm invasive breast carcinomaCancer101174559PubMed Tabar, L, Tony Chen, HH, Amy Yen, MF,  et al. 2004Mammographic tumor features can predict long-term outcomes reliably in women with 1–14-mm invasive breast carcinomaCancer101174559PubMed
12.
go back to reference Gajdos, C, Tartter, PI, Bleiweiss, IJ 1999Lymphatic invasion, tumor size, and age are independent predictors of axillary lymph node metastases in women with T1 breast cancersAnn Surg2306926PubMed Gajdos, C, Tartter, PI, Bleiweiss, IJ 1999Lymphatic invasion, tumor size, and age are independent predictors of axillary lymph node metastases in women with T1 breast cancersAnn Surg2306926PubMed
13.
go back to reference Crivellari, D, Bonetti, M, Castiglione-Gertsch, M, et al. 2000Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: the International Breast Cancer Study Group Trial VIIJ Clin Oncol18141222PubMed Crivellari, D, Bonetti, M, Castiglione-Gertsch, M,  et al. 2000Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: the International Breast Cancer Study Group Trial VIIJ Clin Oncol18141222PubMed
14.
go back to reference van de Vijver, MJ, He, YD, van’t Veer, LJ, et al. 2002A gene-expression signature as a predictor of survival in breast cancerN Engl J Med34719992009CrossRefPubMed van de Vijver, MJ, He, YD, van’t Veer, LJ,  et al. 2002A gene-expression signature as a predictor of survival in breast cancerN Engl J Med34719992009CrossRefPubMed
15.
go back to reference Ma, XJ, Wang, Z, Ryan, PD, et al. 2004A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifenCancer Cell560716PubMed Ma, XJ, Wang, Z, Ryan, PD,  et al. 2004A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifenCancer Cell560716PubMed
16.
go back to reference Schwartz, GF, Hortobagyi, GN 2004Consensus Conference Committee. Proceedings of the consensus conference on neoadjuvant chemotherapy in carcinoma of the breast, April 26–28, 2003, Philadelphia, PennsylvaniaCancer100251232PubMed Schwartz, GF, Hortobagyi, GN 2004Consensus Conference Committee. Proceedings of the consensus conference on neoadjuvant chemotherapy in carcinoma of the breast, April 26–28, 2003, Philadelphia, PennsylvaniaCancer100251232PubMed
17.
go back to reference Holleman, A, Cheok, MH, Boer, ML, et al. 2004Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatmentN Engl J Med35153342PubMed Holleman, A, Cheok, MH, Boer, ML,  et al. 2004Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatmentN Engl J Med35153342PubMed
18.
go back to reference Gervasoni, JE,Jr, Taneja, C, Chung, MA, et al. 2000Biologic and clinical significance of lymphadenectomySurg Clin North Am80163173PubMed Gervasoni, JE,Jr, Taneja, C, Chung, MA,  et al. 2000Biologic and clinical significance of lymphadenectomySurg Clin North Am80163173PubMed
19.
go back to reference Nathanson, SD 2003Insights into the mechanisms of lymph node metastasisCancer9841323PubMed Nathanson, SD 2003Insights into the mechanisms of lymph node metastasisCancer9841323PubMed
20.
go back to reference Cady, B 1998Is axillary lymph node dissection necessary in routine management of breast cancer? NoPrinciples Pract Oncol12112 Cady, B 1998Is axillary lymph node dissection necessary in routine management of breast cancer? NoPrinciples Pract Oncol12112
Metadata
Title
Simplification of Breast Cancer Surgery
Author
Blake Cady, MD
Publication date
01-01-2005
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 1/2005
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/ASO.2005.11.916

Other articles of this Issue 1/2005

Annals of Surgical Oncology 1/2005 Go to the issue

OriginalPaper

Forthcoming Reports